当前位置:
X-MOL 学术
›
Nat. Rev. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The NLRP3 inflammasome in acute myocardial infarction
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-11-16 , DOI: 10.1038/nrcardio.2017.161 Stefano Toldo , Antonio Abbate
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-11-16 , DOI: 10.1038/nrcardio.2017.161 Stefano Toldo , Antonio Abbate
The NLRP3 inflammasome in acute myocardial infarction , isJats=true)
中文翻译:
急性心肌梗死中的NLRP3炎性小体
急性心肌梗死中的NLRP3炎性小体 ,isJats = true)
更新日期:2017-11-16
The NLRP3 inflammasome in acute myocardial infarction, Published online: 16 November 2017; doi:10.1038/nrcardio.2017.161
NatureArticleSnippet(type=short-summary, markup=Ischaemic injury during an acute myocardial infarction (AMI) event is followed by an intense inflammatory response that occurs after reperfusion. The inflammasome is a protein complex involved in the regulation of this inflammatory response. In this Review, Toldo and Abbate summarize evidence supporting the therapeutic value of inflammasome-targeted strategies in the context of AMI.
中文翻译:
急性心肌梗死中的NLRP3炎性小体
急性心肌梗死中的NLRP3炎性小体
急性心肌梗死中的NLRP3炎性小体,在线发布:2017年11月16日; doi:10.1038 / nrcardio.2017.161
NatureArticleSnippet(type = short-summary,markup =急性心肌梗塞(AMI)事件期间的缺血性损伤之后是再灌注后发生的强烈炎症反应。炎性小体是一种蛋白质复合物,参与调节这种炎症反应。在本综述中,Toldo和Abbate总结了支持以炎性体为靶点的策略在AMI中具有治疗价值的证据。